AnaptysBio, Inc.
(NASDAQ : ANAB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. 0.71%579.812.7%$671.17m
AMGNAmgen, Inc. -0.36%227.161.3%$582.50m
GILDGilead Sciences, Inc. 0.20%60.791.0%$581.98m
VRTXVertex Pharmaceuticals, Inc. 0.71%211.581.9%$512.07m
ILMNIllumina, Inc. -0.73%323.553.5%$494.75m
MRNAModerna, Inc. -0.44%70.530.0%$473.04m
ARRYArray BioPharma Inc. -4.42%42.0014.2%$403.84m
IMMUImmunomedics, Inc. 0.00%87.8611.0%$392.45m
NVAXNovavax, Inc. -0.49%93.1396.5%$309.58m
ALXNAlexion Pharmaceuticals, Inc. 1.62%121.612.0%$277.29m
BIIBBiogen, Inc. -0.68%265.001.7%$264.24m
EXASEXACT Sciences Corp. 2.44%109.7020.7%$241.86m
BNTXBioNTech SE 2.70%88.690.0%$221.27m
SRNESorrento Therapeutics, Inc. -2.42%8.081.4%$162.95m
SGENSeagen Inc. -1.86%196.926.0%$157.61m

Company Profile

AnaptysBio, Inc. is a clinical stage biotechnology company, which engages in developing antibody product candidates focused on unmet medical needs in inflammation. Its products pipeline include ANB020, ANB019, and checkpoint receptor agonist antibodies. The company was founded by Andrew B. Cubitt, William J. Boyle and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.